Active Ingredient: DARIFENACIN HYDROBROMIDE
Proprietary Name: DARIFENACIN HYDROBROMIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 7.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A205550
Product Number: 001
Approval Date: Oct 12, 2016
Applicant Holder Full Name: JUBILANT GENERICS LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information